Study finds higher drug co-pays discourage patients from starting treatment

Patients newly diagnosed with hypertension, diabetes or high cholesterol are significantly more likely to delay initiating recommended drug treatment if they face higher co-payments for medications, according to a new RAND Corporation study.

If you want to include this story in your blog, copy and paste this formatted text: